Press coverage about Marrone Bio Innovations (NASDAQ:MBII) has trended somewhat positive on Thursday, Accern reports. The research group scores the sentiment of press coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Marrone Bio Innovations earned a daily sentiment score of 0.12 on Accern’s scale. Accern also gave media headlines about the basic materials company an impact score of 46.7899668772512 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Shares of Marrone Bio Innovations (MBII) traded down $0.09 on Thursday, hitting $1.05. The stock had a trading volume of 164,800 shares, compared to its average volume of 90,914. Marrone Bio Innovations has a twelve month low of $0.85 and a twelve month high of $2.61. The company has a debt-to-equity ratio of -1.14, a quick ratio of 0.36 and a current ratio of 0.69.

Several analysts have recently issued reports on the company. ValuEngine cut Marrone Bio Innovations from a “sell” rating to a “strong sell” rating in a report on Friday, September 1st. HC Wainwright set a $4.00 price objective on Marrone Bio Innovations and gave the stock a “buy” rating in a report on Tuesday, August 15th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating to the stock. Marrone Bio Innovations currently has an average rating of “Hold” and an average target price of $2.50.

ILLEGAL ACTIVITY NOTICE: This article was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this article on another site, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The correct version of this article can be viewed at

Marrone Bio Innovations Company Profile

Marrone Bio Innovations, Inc offers bio-based pest management and plant health products. The Company’s bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate and Majestene.

Insider Buying and Selling by Quarter for Marrone Bio Innovations (NASDAQ:MBII)

Receive News & Stock Ratings for Marrone Bio Innovations Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marrone Bio Innovations Inc. and related stocks with our FREE daily email newsletter.